title: Letter to the Editor on "Rivaroxaban Use for Thrombosis Prophylaxis is Associated With Early Periprosthetic Joint Infection".
authors.affiliation: Department of Orthopedics and Traumatology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia; School of Medicine, Universidad de Los Andes, Bogotá, Colombia; School of Medicine, Universidad del Rosario, Bogotá, Colombia.
authors.forename: Adolfo M
authors.initials: AM
authors.lastname: Llinás
authors.affiliation: Department of Orthopedics and Traumatology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia.
authors.forename: Maria P
authors.initials: MP
authors.lastname: Bautista
authors.affiliation: Department of Orthopedics and Traumatology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia; School of Medicine, Universidad de Los Andes, Bogotá, Colombia; School of Medicine, Universidad del Rosario, Bogotá, Colombia.
authors.forename: Guillermo A
authors.initials: GA
authors.lastname: Bonilla
authors.affiliation: Department of Orthopedics and Traumatology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia.
authors.forename: Meilyn A
authors.initials: MA
authors.lastname: Muskus
authors.affiliation: Department of Orthopedics and Traumatology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia.
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Monsalvo
mesh_terms: D000925:Anticoagulants; D001170:Arthritis, Infectious; D006801:Humans; D000069552:Rivaroxaban; D013927:Thrombosis
chemical_list: D000925:Anticoagulants; D000069552:Rivaroxaban